© 2020 MJH Life Sciences and AJMC. All rights reserved.
© 2020 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
October 18, 2020
The authors, from RxCrossroads by McKesson, discuss the impact of copay accumulator and maximizer programs.
October 13, 2020
As health care costs rise, especially for patients with complex conditions, a major barrier to access is the disconnect between medical benefits and pharmacy benefits.
September 29, 2020
Available in patients’ own communities, novel clinical trials are making an impact in the fight against cancer.
September 17, 2020
Gavreto was granted accelerated approval by the FDA on September 4, 2020, for the treatment of adult patients with metastatic RET fusion-positive non–small cell lung cancer (NSCLC).
August 24, 2020
Inqovi was approved by the FDA on July 7, 2020, for the treatment of adults with intermediate and high-risk myelodysplastic syndromes (MDS) including chronic myelomonocytic leukemia (CMML).
August 14, 2020
The CDC is exercising an option of an existing contract with McKesson for this effort.